Thank you for your interest in the Office Based Opioid Treatment Seminar, sponsored by the American Osteopathic Academy of Addiction Medicine.

As you know, the treatment of opioid addiction is complex, including addiction to prescription opioid analgesics such as oxycodone, hydrocodone, morphine, and other opioids with abuse potential. While the treatment of opioid dependence with medications has previously been limited to the methadone clinic system, Federal legislation now allows for treatment of this disorder by qualified physicians using buprenorphine in an office-based setting. By completing this self-study course, along with a live seminar, you will also qualify for category a) 1A-AOA CME credit for the live portion of study; b) category 1B-AOA CME credit for the self study, and c) 4 hours AAFP Prescribed Credit hours for live seminar, which are eligible for the AMA’s Physician Recognition Award Credit.

Please review the slides online, or print them out for your convenience. Once you complete the course, please:

1. Complete the online registration form and test.
2. Sign up for a live seminar sponsored by AOAAM. See the calendar of courses on this website, or register online at www.docoptin.com.
3. Complete the waiver of eligibility and take it with you to the seminar. Our staff will forward this to the Center for Substance Abuse Treatment once it is verified that you have completed 8-hours of training and have successfully completed the online test. If you complete the waiver after attending a live seminar, please include a cover page with your name, contact information and the seminar attended and fax to 708-401-0360.

If you have any questions, please contact Nina Albano Vidmer at nvidmer@aoaam.org or call us at 708-338-0760.

Four hour on-line course documents

SLIDE 1 INTRODUCTION AND OVERVIEW OF DATA 2000-2006.pdf
SLIDE 2 GENERAL BUP PHARMACOLOGY.pdf
SLIDE 3 PSYCHIATRIC COMORBIDITIES 2006.pdf
SLIDE 4 MEDICAL COMORBIDITY 2006.pdf
SLIDE 6 EFFICACY AND SAFETY OF BUPRENORPHINE 2006.pdf
SLIDE 7 CLINICAL OFFICE MANAGEMENT and UDS 2006.pdf
SLIDE 8 CONFIDENTIALITY AND MEDICAL RECORD KEEPING 2006.pdf

Eight hour on-line course documents

Slide 1-Introduction and DATA 2006 .pdf
Slide 2-Basic Opioid and Bup Pharmacology.pdf
Slide 3-Psychiatric CoMorbidities.pdf
Slide 4-Medical CoMorbidities.pdf
Slide 5-Special Treatment Pops 2006.pdf
Slide 6-Efficacy and Safety of Buprenorphine.pdf
Slide 7-Clinical Office Management.pdf
Slide 8-Confidentiality and Medical Record Keeping.pdf
Slide 9-Intro and Review of the on line course.pdf
Slide 10-Patient Selection and Assessment.pdf
Slide 11-Clinical Use of Buprenorphine.pdf
Slide 12-Waiver Notification.pdf
Slide 13-Pain and Addiction.pdf

Registration

Course Registration and Test

Clinical Tools

Table of Contents.doc
A. Patient Drug Addiction Treatment Act of 2000.doc
B. Info for patients considering treatment with bup.doc
C. Info families of patients considering bup treatment.doc
D. Checklist for personnel who answer bup initial inquiries.doc
E. Form for personnel who answer initial inquiries.doc
F. DSM IV criteria for diagnosis of opiate dependence.doc
G. DSM IV worksheet.doc
H. Clinical Opiate Withdrawal Scale (COWS).doc
I. COWS worksheet.doc
J. Expectations the physician may want to convey to the patient.doc
K. Patient information and consent to treatment.doc
L. Patient information and agreement for treatment.doc
M. Patient information and questionnaire.doc
N. List of patient responsibilities and agreement.doc
O. Patient information and consent form.doc
P. Consent for Release of Information.doc
Q. Intake History and Physical Sample 1.doc
R. Intake History and Physical Sample 2.doc
S. Intake questionnaire for treatment planning for new patient.doc
T. Patient management at follow-up appointments.doc
U. Sample progress notes.doc
V. Sample form for Medication Inventory.doc
W. Billing Information.doc
Complete library (zip file)
Urine Drug Testing in Clinical Practice